JPMorgan raises target for Aflac stock from USD 116.00 to USD 119.00

Published on 10/16/2026 at 09:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue hit USD 4.22 billion versus USD 4.11 billion expected. Aflac stock costs EUR 105.20 on October 16, 2026 at a USD 59.3 billion market value.

Analyst target and reporting date

JPMorgan lifted its Aflac target from USD 116.00 to USD 119.00 on October 15, 2026.
Second-quarter revenue reached USD 4.22 billion against USD 4.11 billion expected, while adjusted earnings per share were USD 1.75.
Aflac stock traded at EUR 105.20 at 9:38 a.m. CEST at Lang & Schwarz on October 16, 2026.
Third-quarter results are scheduled for November 4, 2026.

Isometrische Grafik: Versicherungsantrag, Prüfung und Auszahlung — AFLAC Inc. isometric 3D insurance claim process application review payout ISIN US0010551028, Illustration mit AI erstellt.

Aflac Incorporated (ISIN US0010551028) was trading at EUR 105.20 at Lang & Schwarz on October 16, 2026, at 9:38 a.m. CEST. The latest catalyst is JPMorgan's decision to raise its Aflac price target from USD 116.00 to USD 119.00 while retaining a Neutral rating, as Markets Insider reported on October 15, 2026.

JPMorgan sees a USD 119 target

The target increase came in a third-quarter earnings preview for life insurers. JPMorgan said the near-term picture contains headwinds, while the longer-term outlook offers more support. The change gives the analyst view a constructive tilt without removing the Neutral rating.

Analyst views remain mixed. MarketBeat listed a consensus Hold rating and an average target of USD 117.20 on October 15, 2026, alongside eight Hold, three Buy, one Strong Buy and four Sell ratings.

What did the second quarter deliver?

Aflac reported USD 4.22 billion of revenue for the second quarter, above the USD 4.11 billion consensus, but adjusted earnings per share of USD 1.75 missed the USD 1.76 estimate. Revenue was down 1.00 percent from the year-earlier quarter, when earnings per share were USD 1.78, according to MarketBeat on October 13, 2026. The combination points to resilient revenue demand but a tighter earnings comparison.

Three dated signals for Aflac

On August 6, 2026, Aflac reported second-quarter revenue of USD 4.22 billion and adjusted earnings per share of USD 1.75. On October 13, 2026, Bank of America lowered its target from USD 137.00 to USD 133.00 while keeping a Buy rating. On October 15, 2026, JPMorgan raised its target from USD 116.00 to USD 119.00 and retained Neutral.

Results arrive November 4

Aflac will release third-quarter 2026 results after the market closes on November 4, 2026, followed by an investor webcast at 8:00 a.m. ET on November 5, 2026, according to the company's investor release dated September 30, 2026.

Price and valuation context

Aflac's market capitalization was USD 59.3 billion on October 15, 2026. The insurer operates in supplemental health and life insurance in the United States and Japan, with products spanning accident, cancer, critical illness, hospital, disability, dental, vision and life coverage.

Aflac stock was trading at EUR 105.20 at Lang & Schwarz on October 16, 2026 at 9:38 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Aflac stock.